IDEXX Laboratories (IDXX) PT Raised to $550 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $672.04 --0%
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
JPMorgan analyst Chris Schott raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $550.00 (from $525.00) while maintaining a Overweight rating.
You May Also Be Interested In
- IDEXX Laboratories (IDXX) PT Raised to $770 at Jefferies
- Litalico Inc (7366:JP) PT Raised to JPY2,870 at Nomura/Instinet
- Muyuan Foods Co Ltd (002714:CH) PT Raised to RMB69 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
